Clinical Trials Browser

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colonic Neoplasms

Biliary Tract Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Esophagogastric Cancer

Esophageal Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms

Colorectal Cancer Metastatic

Colorectal Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Rectal Neoplasms

Liver Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Gastrointestinal Neoplasms

Colorectal Neoplasms

Clinical Trials

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Pemetrexed and TAS-102 in Combination With Bevacizumab in Refractory Colorectal Cancer

Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer

Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study

Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy

Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Pemetrexed and Erlotinib for Metastatic Colorectal Cancer

Phase II Study of Pemetrexed in Advanced or Recurrent Gastric Cancer After Chemotherapy

Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery

Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers

A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer

Study of Pemetrexed for Second-Line Pancreas Cancer

Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic

Gemcitabine in Combination With Pemetrexed Long Term Infusion in the Treatment of Pretreated Metastatic Colorectal Cancer Patients

PG

A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer

Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer

A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer.

A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver

Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer

Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is Metastatic

Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma

A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.